Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study

BACKGROUND: Rasagiline is a monoamine oxidase-B inhibitor used for Parkinson’s disease (PD) treatment, but its effectiveness on Chinese patients is unclear. This study aimed to evaluate the efficacy and safety of rasagiline monotherapy in Chinese patients with early PD. METHODS: A 26-weeks, randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhenxin, Wang, Jian, Chen, Shengdi, Liu, Chunfeng, Zhang, Baorong, Peng, Rong, Sun, Shenggang, Sun, Xiangru, Zhao, Gang, Qu, Qiumin, Li, Yansheng, Zhu, Suiqiang, Pan, Xiaoping, Shao, Ming, Wang, Yanping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282325/
https://www.ncbi.nlm.nih.gov/pubmed/30534374
http://dx.doi.org/10.1186/s40035-018-0137-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282325/
https://www.ncbi.nlm.nih.gov/pubmed/30534374
http://dx.doi.org/10.1186/s40035-018-0137-5

Ejemplares similares